Naroparcil
Product Specifications
Target
Factor Xa|||Thrombin
Related Pathways
Metabolism|||Proteases/Proteasome
Purity
0.9999
Bioactivity
Naroparcil, an orally available thioglycoside analog of 4-methylumbelliferyl ?-D-xyloside, showed antithrombotic effects in the Wessler sludge model of venous thrombosis (jugular vein) .Naroparcil enhanced the formation of the thrombin/heparin cofactor II complex, induced dermatophyte sulfate-like substances in plasma from treated rabbits appearance, but reduced the formation of thrombin/antithrombin III complexes in plasma incubated with (125I) -human alpha-thrombin.
Smiles
S(C1=CC=C(C(=O)C2=CC=C(C#N)C=C2)C=C1)[C@H]3[C@H](O)[C@@H](O)[C@H](O)CS3
Molecular Formula
C19H17NO4S2
Molecular Weight
387.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/153428B2-97CB-4B6C-B5AB-627C9A31AC08/T68002
CAS Number
120819-70-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15196717 1 Vial
Lentiviral mouse Tmem254a shRNA (UAS) - Lentiviral mouse Tmem254a shRNA (UAS, RFP) plasmid
Ask
View Details